Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Czechia
Clinical trial register · Czechia

Clinical Trials in Czechia

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1529 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:17 UTC
1529
Studies in scope
all four open statuses
792
Recruiting now
open to new participants
306
Lead sponsors
across recruiting studies
Top sites
Prague 3 Hradec Králové 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals69 Charles University, Czech Republic56 AstraZeneca51 Eli Lilly and Company48 Merck Sharp & Dohme LLC47 Janssen Research & Development, LLC46 Sanofi40 AbbVie36 Pfizer36 University Hospital Ostrava31 Bristol-Myers Squibb30 Hoffmann-La Roche29 Takeda20 Amgen20 General University Hospital, Prague18 Novo Nordisk A/S18 Boehringer Ingelheim18 Masaryk University16 Institute for Clinical and Experimental Medicine16 GlaxoSmithKline12 University Hospital Hradec Kralove12 argenx12 Brno University Hospital11 St. Anne's University Hospital Brno, Czech Republic11 Bayer11 Masaryk Memorial Cancer Institute11 Genmab11 The Institute of Molecular and Translational Medicine, Czech Republic10 Incyte Corporation10 Palacky University9 University Hospital Olomouc9 Biogen8 University Hospital, Motol8 Celgene8 Daiichi Sankyo8 University Hospital Pilsen8 UCB Biopharma SRL8 BeOne Medicines8 Boston Scientific Corporation8 Alexion Pharmaceuticals, Inc.8 Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.7 Institute of Health Information and Statistics of the Czech Republic7 Loxo Oncology, Inc.7 Gilead Sciences7 Exelixis7 Abbott Medical Devices7 Faculty Hospital Kralovske Vinohrady7 Ipsen7 European Organisation for Research and Treatment of Cancer - EORTC6 University of Alberta6 Regeneron Pharmaceuticals6 Tomas Bata Hospital, Czech Republic5 Acerta Pharma BV5 Biotronik SE & Co. KG5 Czech Technical University in Prague5 European Myeloma Network B.V.5 National Institute of Mental Health, Czech Republic4 Swedish Orphan Biovitrum4 Seagen, a wholly owned subsidiary of Pfizer4 ACADIA Pharmaceuticals Inc.4 Alkermes, Inc.4 Genzyme, a Sanofi Company4 Charite University, Berlin, Germany4 Nemocnice AGEL Trinec-Podlesi a.s.4 Astellas Pharma Global Development, Inc.4 Medtronic4 Immunovant Sciences GmbH4 University of Ostrava4 Alnylam Pharmaceuticals4 Arrowhead Pharmaceuticals3 Spyre Therapeutics, Inc.3 Mirati Therapeutics Inc.3 Astria Therapeutics, Inc.3 Aesculap AG3 Karyopharm Therapeutics Inc3 Na Homolce Hospital3 Viatris Innovation GmbH3 Insel Gruppe AG, University Hospital Bern3 MoonLake Immunotherapeutics AG3 Ascentage Pharma Group Inc.3 Military University Hospital, Prague3 Octapharma3 Genentech, Inc.3 CSL Behring3 ADARx Pharmaceuticals, Inc.3 Agios Pharmaceuticals, Inc.3 Vertex Pharmaceuticals Incorporated3 Medtronic Cardiac Ablation Solutions3 Institute of Hematology and Blood Transfusion, Czech Republic3 Leiden University Medical Center3 EMD Serono Research & Development Institute, Inc.3 Intra-Cellular Therapies, Inc.3 Zenas BioPharma (USA), LLC3 Tesaro, Inc.3 BTL Industries Ltd.3 Xenon Pharmaceuticals Inc.3 Otsuka Pharmaceutical Development & Commercialization, Inc.3 Abivax S.A.3 Aragon Pharmaceuticals, Inc.3 Gustave Roussy, Cancer Campus, Grand Paris3 AOP Orphan Pharmaceuticals AG3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Denali Therapeutics Inc.3 Copenhagen University Hospital, Rigshospitalet3 BioNTech SE3 OrbusNeich2 Celcuity Inc2 EyeBiotech Ltd.2 Institut de Recherches Internationales Servier2 Universitätsklinikum Hamburg-Eppendorf2 Lexeo Therapeutics2 Cogent Biosciences, Inc.2 Kardium Inc.2 University Medical Center Groningen2 Heidelberg University2 NeuroDerm Ltd.2 Ferring Pharmaceuticals2 Apogee Therapeutics, Inc.2 Eisai Inc.2 University Hospital Muenster2 Glycomine, Inc.2 VectivBio AG2 Merz Therapeutics GmbH2 Kailera2 Sun Pharmaceutical Industries Limited2 Pharming Technologies B.V.2 Colorado Prevention Center2 Institute of Spa and Balneology, public research institution2 ADC Therapeutics S.A.2 Chugai Pharmaceutical2 Thomayer University Hospital2 Neurocrine Biosciences2 NovoCure GmbH2 EyePoint Pharmaceuticals, Inc.2 Stichting European Myeloma Network2 Ionis Pharmaceuticals, Inc.2 Anthos Therapeutics, Inc.2 Mirum Pharmaceuticals, Inc.2 Seaport Therapeutics2 Pulse Biosciences, Inc.2 Czech Lymphoma Study Group2 Insmed Incorporated2 Bluefin Biomedicine, Inc.2 Apellis Pharmaceuticals, Inc.2 Olema Oncology, Inc.2 University of Birmingham2 Upstream Bio Inc.2 Arcus Biosciences, Inc.2 Teva Branded Pharmaceutical Products R&D LLC2 Fresenius Medical Care Deutschland GmbH2 European Society of Cardiology2 icometrix2 Kartos Therapeutics, Inc.2 Duke University2 Weill Medical College of Cornell University2 Niguarda Hospital2 NewAmsterdam Pharma2 Ascletis Pharma (China) Co., Limited2 The Central and Eastern European Gynecologic Oncology Group2 Alfasigma S.p.A.2 Janssen-Cilag Ltd.2 Celldex Therapeutics2 University College Dublin2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 CardioFocus2 Revolution Medicines, Inc.2 Biohaven Therapeutics Ltd.2 PedAL BCU, LLC1 pharmaand GmbH1 Luye Pharma Group Ltd.1 Hansa Biopharma AB1 Gossamer Bio USA, Inc.1 Kedrion S.p.A.1 Javier P. Gisbert1 Jazz Pharmaceuticals1 University of California, Davis1 Eikon Therapeutics1 University Hospital Tuebingen1 H. Lundbeck A/S1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 Tenax Therapeutics, Inc.1 SOTIO Biotech a.s.1 KU Leuven1 JaxBio Ltd1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 SystImmune Inc.1 European Association of Urology Research Foundation1 Jan Žatecký1 College of Physical Education and Sport PALESTRA1 Martin Harazim1 EPC Education s.r.o.1 KeyBioscience AG1 Vedanta Biosciences, Inc.1 COMPASS Pathways1 Servier Bio-Innovation LLC1 Priovant Therapeutics, Inc.1 IntraBio Inc1 Janssen Pharmaceutica N.V., Belgium1 MRM Health NV1 Stealth BioTherapeutics Inc.1 Abcentra1 Children's Oncology Group1 Primex ehf1 Dianthus Therapeutics1 Morten H. Bestle1 RHEACELL GmbH & Co. KG1 LinkoCare Life Sciences AB1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Dizal Pharmaceuticals1 FineHeart1 Bambino Gesù Hospital and Research Institute1 VarmX B.V.1 Orchestra BioMed, Inc1 University of Regensburg1 Actelion1 UNICANCER1 Dimerix Bioscience Pty Ltd1 Kyowa Kirin Pharmaceutical Development Ltd1 AtriCure, Inc.1 AVEO Pharmaceuticals, Inc.1 Philipp Dutkowski1 BioCryst Pharmaceuticals1 iTeos Therapeutics1 Philip Morris Products S.A.1 Lexicon Pharmaceuticals1 Pulmovant, Inc.1 Definium Therapeutics US, Inc.1 Applied Therapeutics, Inc.1 Biotest1 Alimentiv Inc.1 Motol and Homolka University Hospital1 Corvia Medical1 Alumis Inc1 PedNet Haemophilia Research Foundation1 Stimvia s.r.o.1 Pharmacyclics Switzerland GmbH1 Perfect Lens, LLC1 Stichting Hemato-Oncologie voor Volwassenen Nederland1 AlgoTherapeutix1 Institut Claudius Regaud1 Moleculin Biotech, Inc.1 Bausch & Lomb GmbH1 Annexon, Inc.1 Erasca, Inc.1 IRCCS San Raffaele1 Shanghai Henlius Biotech1 Zuyderland Medisch Centrum1 Gemini Eye Clinic1 Ever Neuro Pharma GmbH1 Biohaven Pharmaceuticals, Inc.1 Carl Zeiss Meditec AG1 Cerevance1 Jiangsu HengRui Medicine Co., Ltd.1 Merz Pharmaceuticals GmbH1 Centre Hospitalier Universitaire de Besancon1 GLSMED Learning Health S.A.1 Blueprint Medicines Corporation1 Curis, Inc.1 Cytokinetics1 Cutting Edge SAS1 Aura Biosciences1 Oslo University Hospital1 Calcilytix Therapeutics, Inc., a BridgeBio company1 Zai Lab (Shanghai) Co., Ltd.1 INNODIA iVZW1 Nuvalent Inc.1 European Foundation for Study of Chronic Liver Failure1 Nektar Therapeutics1 Vor Biopharma1 Odyssey Therapeutics, Inc.1 Cellectar Biosciences, Inc.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Lukas Vanek1 Mitera Hospital1 Rede Optimus Hospitalar SA1 King's College London1 Sitala Bio LTD1 Xentria, Inc.1 University of Cambridge1 Ono Pharmaceutical Co., Ltd.1 VDI Technologies1 St. Anna Kinderkrebsforschung1 North Eastern German Society of Gynaecological Oncology1 Immunocore Ltd1 Region Örebro County1 Palisade Bio1 Provention Bio, a Sanofi Company1 Faron Pharmaceuticals Ltd1 Eidos Therapeutics, a BridgeBio company1 Pharvaris Netherlands B.V.1 Princess Maxima Center for Pediatric Oncology1 Medical University of Vienna1 Lipidica, a.s.1 Stemline Therapeutics, Inc.1 Associazione Italiana Ematologia Oncologia Pediatrica1 Sanofi Pasteur, a Sanofi Company1 Arga Medtech SA1 CIATRIX, INC.1 Rare Thyroid Therapeutics International AB1 The Hospital for Sick Children1 MedSIR1 SOTIO Biotech AG1 Exciva GmbH1 Airway Therapeutics, Inc.1 Hamlet Pharma AB1 4TEEN4 Pharmaceuticals GmbH1 Myopowers Medical Technologies France SAS1 Tanabe Pharma America, Inc.1 Johnson & Johnson Enterprise Innovation Inc.1 Pregnolia AG1 Janssen Scientific Affairs, LLC1 Triveni Bio1 Isabelle Herter-Aeberli1 Britannia Pharmaceuticals Ltd.1 Instituto Portugues Oncologia de Lisboa Francisco Gentil1 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 Intellia Therapeutics1 Append Medical Ltd.1 Dompé Farmaceutici S.p.A1 Kura Oncology, Inc.1 Institut Curie1 Azienda Unita Sanitaria Locale di Piacenza1 X4 Pharmaceuticals1 MapLight Therapeutics1 Emergency Medical Service, Prague1 Philippe ROUSSELOT1 IO Biotech1 University of Zurich1 Relay Therapeutics, Inc.1 BioVentrix1 CeleCor Therapeutics1 Masarykova Univerzita1 ONL Therapeutics1 Cortex1 SpliSense Ltd.1 Martina Lojova1 Avalyn Pharma Inc.1 Genexine, Inc.1 VDyne, Inc.1 Taiho Oncology, Inc.1 AriBio Co., Ltd.1 University Hospital, Bonn1 Indiana University1 Dr. Yaroslav Winter1 CoreMap Inc.1 Innovacell GmbH1 Almirall, S.A.1 ITM Solucin GmbH1 IDEAYA Biosciences1 BeiGene1 Foundry Innovation & Research 1, Limited (FIRE1)1 International Extranodal Lymphoma Study Group (IELSG)1 Javelin Medical1 SecuraBio1 University in Zielona Góra1 Axon Therapies, Inc.1 Marie Lulková1 Western Sydney Local Health District1 Nemocnice Kolín1 Corteria Pharmaceuticals1 United Therapeutics1 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 Orchid Pharma Europe GmbH1 Centre Leon Berard1 Draig Therapeutics Ltd1 National and Kapodistrian University of Athens1 Protagonist Therapeutics, Inc.1 Generate Biomedicines1 Kymera Therapeutics, Inc.1 Australasian Gastro-Intestinal Trials Group1 Chiesi Farmaceutici S.p.A.1 Bicara Therapeutics1 Santhera Pharmaceuticals1 HUYABIO International, LLC.1 European Clinical Research Alliance for Infectious Diseases (ECRAID)1 Sirius Therapeutics Co., Ltd.1 University Hospital Freiburg1 BackBeat Medical Inc1 Medtronic Cardiac Rhythm and Heart Failure1 St George's, University of London1 Julius Clinical1 Insud Pharma1 Abiomed Inc.1 Vanda Pharmaceuticals1 Deciphera Pharmaceuticals, LLC1 Day One Biopharmaceuticals, Inc.1 Vojtech Melenovsky, MD, PhD1 Universitaire Ziekenhuizen KU Leuven1 Manuel Monreal1 Vladimíra Dostálová1 LMU Klinikum1 Eagle Pharmaceuticals, Inc.1 Pomeranian Medical University Szczecin1 KARDI AI Technologies s.r.o.1 Imagine Institute1 Prilenia1 Nikola Janovska1 PhenoNet, Inc.1 eleva GmbH1 Bellus Health Inc. - a GSK company1 University Medicine Greifswald1 Italfarmaco1 Centre Hospitalier Universitaire de Liege1 St. Justine's Hospital1 Rigel Pharmaceuticals1 MEBSTER1 Inventiva Pharma1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Interni hematologicka klinika FNKV1 Grifols Therapeutics LLC1 International CTEPH Association1 Redx Pharma Ltd1 NS Pharma, Inc.1 Apollo Therapeutics Ltd1 Alentis Therapeutics AG1 Memorial Sloan Kettering Cancer Center1 ENDOPLY1 Elena Gurkova1 Poitiers University Hospital1 BioAegis Therapeutics Inc.1 AnaCardio AB1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 The University of Texas Health Science Center, Houston1 Santen SAS1 Summit Therapeutics1 Marketa Bonaventurova1 CanariaBio Inc.1 Guerbet1 Philips Clinical & Medical Affairs Global1 TG Therapeutics, Inc.1 Kite, A Gilead Company1 M.A. Med Alliance S.A.1 Belite Bio, Inc1 Digma Medical Ltd.1 Silesian Hospital in Opava1 Epics Therapeutics1 Miltenyi Biomedicine GmbH1 Alleviant Medical, Inc.1 LUMA Vision Ltd.1 Martin Schrappe1 Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)1 Cybin IRL Limited1 University of Massachusetts, Worcester1 UMC Utrecht1 medac GmbH1 Womed1 Delcath Systems Inc.1 Menarini Group1 Research Maatschap Cardiologen Rotterdam Zuid1 Gesynta Pharma AB1 Baxalta now part of Shire1 GT Metabolic Solutions, Inc.1 Xcovery Holdings, Inc.1 IRCCS San Raffaele Roma1 University Hospital, Geneva1 Philipp Homan1 University Hospital, Gasthuisberg1 Ancora Heart, Inc.1 Field Medical1 Janssen Biotech, Inc.1 University Hospital, Akershus1 Ultragenyx Pharmaceutical Inc1 Pierre Fabre Medicament1 ALPFA Medical1 Geron Corporation1 Friedreich's Ataxia Research Alliance1 CatalYm GmbH1 Clear sponsor filter
Site location
Prague3 Hradec Králové1
All 2 locations
Target enrolment
to

Trials in this register

3 of 1529 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Hradec Králové, Prague
2023-05-09
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
Phase 3
880
Prague
2023-04-25
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Prague
2023-02-14
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-czechia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,529 studies in total at the last sync on 18 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Czechia?

2 of the 3 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 3 studies
PhaseStudiesRecruitingShare
Phase 332100%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Xenon Pharmaceuticals Inc.32

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Focal Onset Seizures (1) Focal Epilepsy (1) Tonic-Clonic Seizures (1) Primary Generalized Tonic-Clonic Seizures (1)
→

Browse trials by site location

Prague (3) Hradec Králové (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.